Rheumatology

Your Article Summary

See Latest Articles

Anti-Tumor Necrosis Factor-alpha Therapy in Undifferentiated Spondyloarthritis (USpA)
Current Rheumatology Reviews, 09/11/09

Liao H–T et al. – Undifferentiated spondyloarthritis (USpA) include incomplete forms or early phases of definite seronegative spondyloarthritis (SpA) and cases of spondyloarthritis that remain undifferentiated. The treatment of SpA is more conditioned by the disease localization. Non–steroidal anti–inflammatory drugs and disease–modifying antirheumatic drugs are the main therapeutic agents for the treatment of peripheral arthritis in USpA. Tumor necrosis factor–alpha (TNF–alpha) has been detected in sacroiliac joints of patients with SpA.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09

Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

See All of Clinical Pharmacology

Today in Spondylarthropathies...keeping you current

Receive free subspecialty "5-minute updates" via email

Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research , 11/02/09

Agreement between quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis
Journal of Rheumatology, 11/18/09

Recreational Exercise in Rheumatic Diseases
International Journal of Sports Medicine, 10/30/09

See All of Spondylarthropathies